Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.82 +0.02 (+2.73%)
As of: Oct 2, 2026 · 9:56 AM EDT

Rani Therapeutics Holdings (RANI) Change in Receivables (2025)

Updated

Rani Therapeutics Holdings (RANI) recorded Change in Receivables of $2.47 million in Q4 2025.

Analysis

Rani Therapeutics Holdings (RANI) Change in Receivables (2025) Analysis & Trends

For FY2025, Rani Therapeutics Holdings reported Change in Receivables of $2.04 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.47 Mn
Jun 30, 2025 -1.03 Mn
Mar 31, 2025 600,000.00
API Access

Rani Therapeutics Holdings Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=RANI&period=max&api_key=YOUR_API_KEY